Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Mar. 31, 2024
CURRENT ASSETS
Cash	$ 100,731	$ 786,060
Accounts receivable, net	1,517,887	1,468,655
Inventory [Note 3]	1,913,290	1,879,402
Deposits and other receivables	562,245	336,456
Total current assets	4,094,153	4,470,573
Deposits and other receivables [Note 10]	85,000	85,000
Long-term accounts receivable	103,494	149,907
Property and equipment [Note 12]	14,064	15,552
Operating right of use assets [Note 10]	1,124,016	1,221,593
TOTAL ASSETS	5,420,727	5,942,625
CURRENT LIABILITIES
Accounts payable and accrued liabilities [Note 4]	8,089,505	9,473,118
Convertible promissory notes and short term loans [Note 5]	8,499,158	9,376,471
Term loan, current	3,000,000	2,400,000
Derivative liabilities [Note 8]	516,107	991,866
Operating lease obligations, current [Note 10]	475,026	457,371
Total current liabilities	20,579,796	22,698,826
Federally guaranteed loans [Note 7]	870,800	870,800
Term loan [Note 6]	9,436,864	9,985,033
Derivative liabilities [Note 8]	1,323,374	1,435,668
Operating lease obligations	803,380	929,115
TOTAL LIABILITIES	33,014,214	35,919,442
STOCKHOLDERS’ DEFICIENCY
Common stock, $0.001 par value, 125,000,000 shares authorized as at June 30, 2024 and March 31, 2024, respectively. Issued and outstanding common shares: 21,484,396 and 9,353,768 as at June 30, 2024 and March 31, 2024, respectively, and exchangeable shares of 160,672 outstanding as at June 30, 2024 and March 31, 2024, respectively [Note 9]	21,645	9,515
Shares to be issued 321,757 and 324,276 shares of common stock as at June 30, 2024 and March 31, 2024, respectively) [Note 9]	359,709	269,065
Additional paid-in-capital	104,231,071	95,723,083
Accumulated other comprehensive income	55,961	32,378
Accumulated deficit	(134,448,077)	(127,499,785)
Total stockholders’ deficiency	(29,779,690)	(31,465,737)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIENCY	5,420,727	5,942,625
Series B Convertible Redeemable Preferred Stock [Member]
MEZZANINE EQUITY
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 shares authorized as of June 30, 2024 and March 31, 2024, respectively, 405 and 265 shares issued and outstanding as of June 30, 2024 and March 31, 2024, respectively [Note 9]	2,186,203	1,488,920
Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock, value	1	1
Series A Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock, value	$ 0	$ 6